Intent to Grant an Exclusive License of U.S. Government-Owned Inventions
In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license to the invention claimed in the PCT/US2009/060091 (Publication Number WO 2010/042780), entitled “Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus”, to Biomedisyn Corporation with its principal place of business at 12 Indian Trail Road, Woodbridge, Connecticut 06525.
Table of Contents Back to Top
ADDRESSES: Back to Top
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: Back to Top
For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619-6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: Back to Top
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES).
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14802 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P